Objective: Describe a case of deep brain stimulation (DBS) outcome for a patient with pathogenic variants of Shank2 and KMT2B genes.
Background: Prior reports have demonstrated significant improvement of generalized dystonia in KMT2B related dystonia (DYT28). We describe the first case of a positive DBS outcome in a patient with both KMT2B and Shank2 mutations.
Method: Description of clinical case and therapeutic approach.
Results: A 13 year old Caucasian boy with a complex syndrome, characterized by developmental delay, autism, and generalized dystonia, was referred for evaluation for DBS. He presented with hypotonia and global developmental delay starting at 8 months old, and was diagnosed with autism by age 4. He learned to walk, but developed spasticity and dystonia, and became wheelchair-bound by age 7. Trio whole exome sequencing (WES) revealed a pathogenic variant in the Shank2 gene (de novo c.2666dupC, p.P890SfsX32). At age 11, due to progressive worsening of dystonia involving the upper limbs and trunk not explained by the Shank2 variant, WES was re-analyzed revealing a de novo variant of the KMT2B gene (c.7613delC, p.T2539Pf*75). Tetrabenazine and trihexyphenidyl provided limited benefit. Bilateral globus pallidus internus (GPi) DBS was performed. Initial DBS settings were as follows: left–contacts 1+2-: amplitude (amp) 2.0mA, pulse width (pw) 60ms, and frequency (f) 130 hz, right–contacts C+2-: amp 2.0, pw 60, f 130. Within 1 month, he began to show improvement of truncal and limb dystonia, and reduction of dystonic spasms: he was able to sit unassisted upright in his wheelchair, and regained fine motor skills. At last follow-up, DBS settings were: left–contacts 1+2-: amp 4.5, pw 60, f 130, right–contacts C+1-2-3-: amp 4.0, pw 60, f 130. Functional improvement of truncal and limb dystonia was sustained at 2.5 years after DBS.
Conclusion: KMT2B gene variants have now been established as one of the most frequent genetic causes of early onset, generalized dystonia. Additional common features include dysmorphisms, developmental delay, intellectual disability, and seizures. Shank genes are responsible for autism spectrum disorders, often associated with intellectual disability. Previous reports have shown significant improvement of dystonia in patients with KMT2B related dystonia after pallidal DBS. We report here the first case of a patient with both KMT2B and Shank2 mutations who demonstrated significant improvement of dystonia following pallidal DBS.
References: Abel M, Pfister R, Hussein I, Alsalloum F, Onyinzo C, Kappl S, Zech M, Demmel W, Staudt M, Kudernatsch M, Berweck S. Deep Brain Stimulation in KMT2B-Related Dystonia: Case Report and Review of the Literature With Special Emphasis on Dysarthria and Speech. Front Neurol. 2021 May 14;12:662910. doi: 10.3389/fneur.2021.662910. PMID: 34054706; PMCID: PMC8160374.
Cao Z, Yao H, Bao X, Wen Y, Liu B, Wang S, Yang H. DYT28 Responsive to Pallidal Deep Brain Stimulation. Mov Disord Clin Pract. 2019 Dec 26;7(1):97-99. doi: 10.1002/mdc3.12862. PMID: 31970221; PMCID: PMC6962688.
Carecchio M, Invernizzi F, Gonzàlez-Latapi P, Panteghini C, Zorzi G, Romito L, et al. Frequency and phenotypic spectrum of KMT2B dystonia in childhood: a single-center cohort study. Mov Disord. (2019) 34:1516– 27. doi: 10.1002/mds.27771
Cif L, Demailly D, Lin JP, Barwick KE, Sa M, Abela L, et al. KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation. Brain. (2020) 143:3242–61. doi: 10.1093/brain/ awaa304
Dafsari HS, Sprute R, Wunderlich G, Daimagüler HS, Karaca E, Contreras A, Becker K, Schulze-Rhonhof M, Kiening K, Karakulak T, Kloss M, Horn A, Pauls A, Nürnberg P, Altmüller J, Thiele H, Assmann B, Koy A, Cirak S. Novel mutations in KMT2B offer pathophysiological insights into childhood-onset progressive dystonia. J Hum Genet. 2019 Aug;64(8):803-813. doi: 10.1038/s10038-019-0625-1. Epub 2019 Jun 5. Erratum in: J Hum Genet. 2019 Aug 6;: PMID: 31165786.
Kawarai T, Miyamoto R, Nakagawa E, Koichihara R, Sakamoto T, Mure H, Morigaki R, Koizumi H, Oki R, Montecchiani C, Caltagirone C, Orlacchio A, Hattori A, Mashimo H, Izumi Y, Mezaki T, Kumada S, Taniguchi M, Yokochi F, Saitoh S, Goto S, Kaji R. Phenotype variability and allelic heterogeneity in KMT2B-Associated disease. Parkinsonism Relat Disord. 2018 Jul;52:55-61. doi: 10.1016/j.parkreldis.2018.03.022. Epub 2018 Apr 5. PMID: 29653907.
Li XY, Dai LF, Wan XH, Guo Y, Dai Y, Li SL, Fang F, Wang XH, Zhang WH, Liu TH, Xie ZH, Fang T, Wang L, Ding CH. Clinical phenotypes, genotypes and treatment in Chinese dystonia patients with KMT2B variants. Parkinsonism Relat Disord. 2020 Aug;77:76-82. doi: 10.1016/j.parkreldis.2020.06.002. Epub 2020 Jun 9. PMID: 32634684.
Meyer E, Carss KJ, Rankin J, Nichols JM, Grozeva D, Joseph AP, et al. Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia. Nat Genet. (2017) 49:223–37. doi: 10.1038/ ng.3740
Monteiro P, Feng G. SHANK proteins: roles at the synapse and in autism spectrum disorder. Nat Rev Neurosci. 2017 Mar;18(3):147-157. doi: 10.1038/nrn.2016.183. Epub 2017 Feb 9. PMID: 28179641.
Mun JK, Kim AR, Ahn JH, Kim M, Cho JW, Lee JI, Cho KR, Youn J. Successful Pallidal Stimulation in a Patient with KMT2B-Related Dystonia. J Mov Disord. 2020 May;13(2):154-158. doi: 10.14802/jmd.19087. Epub 2020 Apr 6. PMID: 32241076; PMCID: PMC7280936.
Winslow N, Maldonado A, Zayas-Rodriguez L, Lamichhane D. Adult-Onset KMT2B-Related Dystonia Responsive to Deep Brain Stimulation. Mov Disord Clin Pract. 2020 Oct 17;7(8):992-993. doi: 10.1002/mdc3.13093. PMID: 33163573; PMCID: PMC7604663.
Zech M, Boesch S, Maier EM, Borggraefe I, Vill K, Laccone F, et al. Haploinsufficiency of KMT2B, encoding the lysine-specific histone methyltransferase 2b, results in early-onset generalized dystonia. Am J Hum Genet. (2016) 99:1377–87. doi: 10.1016/j.ajhg.2016. 10.010
Zech M, Lam DD, Winkelmann J. Update on KMT2B-Related dystonia. Curr Neurol Neurosci Rep. (2019) 19:92. doi: 10.1007/s11910-019- 1007-y
To cite this abstract in AMA style:
L. Pan, G. Riboldi, A. Mogilner, C. Toro, S. Frucht. DBS for a patient with KMT2B-SHANK2 related dystonia [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/dbs-for-a-patient-with-kmt2b-shank2-related-dystonia/. Accessed November 21, 2024.« Back to 2022 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/dbs-for-a-patient-with-kmt2b-shank2-related-dystonia/